 YARDLEY, Pa., Jan. 25, 2021 GLOBE NEWSWIRE -- Opti N ose, Inc. NASDAQ:OPTN, a pharmaceutical company focused on patients treated by ear, nose and throat ENT and allergy specialists, today announced that the company has granted a non-qualified stock option award to purchase 15,000 shares of its common stock to one new employee as an inducement material for accepting employment with OptiNose. The stock option award was approved by the Compensation Committee of the companys Board of Directors and was granted outside of the OptiNose, Inc. 2010 Stock Incentive Plan in accordance with Nasdaq Listing Rule 5635c4 